Ambrose Healthcare is a high growth specialist pharmaceutical company, established to address ‘market pull’ and provide treatments for rare diseases and the unmet medical needs of patients managed in a hospital or specialist care settings.

It is establishing its product portfolio through the acquisition, licensing and collaborative development of marketed and clinical stage assets, for supply into its core markets of the U.S., Europe, and the Middle East, and through established pharmaceutical companies in other territories.

The company is led by the industry experienced founder Toby Wilson Waterworth and a Leadership Team with a track record and deep international roots in the pharmaceutical industry.

The team is repeating the success and strategy of its previous venture where it built a diversified late-stage clinical pipeline (leading in Phase 3) through global licensing and clinical development, raising $50M in equity and grants in the process. A top 4 Accountancy firm valued the product pipeline at $500M.